Once you’ve determined that LT4 therapy is not achieving the desired symptomatic end points, what are the practical aspects of initiating DTE therapy in the PCP setting? What does the DTE roadmap look like for NP Thyroid® and other DTE formulations?

Once you’ve determined that LT4 therapy is not achieving the desired symptomatic end points, what are the practical aspects of initiating DTE therapy in the PCP setting? What does the DTE roadmap look like for NP Thyroid® and other DTE formulations?

Once you’ve determined that LT4 therapy is not achieving the desired symptomatic end points, what are the practical aspects of initiating DTE therapy in the PCP setting? What does the DTE roadmap look like for NP Thyroid® and other DTE formulations?


Created by

CMEducation Resources IQ&A Thyroid Hormone Replacement Medical Intelligence Zone

Presenter

Christine Kessler, MN, ANP-BC, CNS, BC-ADM, FAANP

Christine Kessler, MN, ANP-BC, CNS, BC-ADM, FAANP

Founder, Nurse Practitioner Metabolic Medicine AssociatesCo-Chair, Metabolic & Endocrine Disease Summit (MEDS) King George, Virginia